Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00097279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label, Randomised Trial to Compare the Efficacy and Safety of NovoLog Mix 70/30 BID in Combination With Metformin and Pioglitazone to Metformin and Pioglitazone Alone in Insulin Naïve Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). The purpose of this study is to test whether biphasic insulin aspart 70/30 is a safe and at least as effective alternative in combination with two oral anti-diabetics compared to the two oral anti-diabetics alone for the control of blood glucose.
Study identification
- NCT ID
- NCT00097279
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 230 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2004 (Type not available)
- Primary completion
- Aug 2005 (Actual)
- Completion
- Aug 2005 (Actual)
- Last update posted
- Jan 11, 2017
2004 – 2005
United States locations
- U.S. sites
- 73
- U.S. states
- 33
- U.S. cities
- 70
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35235 | — |
| Novo Nordisk Investigational Site | Glendale | Arizona | 85306 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85006 | — |
| Novo Nordisk Investigational Site | Searcy | Arkansas | 72143 | — |
| Novo Nordisk Investigational Site | Burlingame | California | 94010 | — |
| Novo Nordisk Investigational Site | Chula Vista | California | 91911 | — |
| Novo Nordisk Investigational Site | Fullerton | California | 92835 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Redwood City | California | 94062 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80262 | — |
| Novo Nordisk Investigational Site | New Britain | Connecticut | 06050 | — |
| Novo Nordisk Investigational Site | Newark | Delaware | 19713 | — |
| Novo Nordisk Investigational Site | Aventura | Florida | 33180 | — |
| Novo Nordisk Investigational Site | Fort Myers | Florida | 33907 | — |
| Novo Nordisk Investigational Site | Hollywood | Florida | 33021 | — |
| Novo Nordisk Investigational Site | Lake Mary | Florida | 32746 | — |
| Novo Nordisk Investigational Site | Melbourne | Florida | 32901 | — |
| Novo Nordisk Investigational Site | Ocala | Florida | 34471 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33024 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | West Palm Beach | Florida | 33401 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30339 | — |
| Novo Nordisk Investigational Site | Columbus | Georgia | 31904 | — |
| Novo Nordisk Investigational Site | Savannah | Georgia | 31406 | — |
| Novo Nordisk Investigational Site | Boise | Idaho | 83702 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Wichita | Kansas | 67205 | — |
| Novo Nordisk Investigational Site | Baton Rouge | Louisiana | 70808 | — |
| Novo Nordisk Investigational Site | Easton | Maryland | 21601 | — |
| Novo Nordisk Investigational Site | Danvers | Massachusetts | 01923 | — |
| Novo Nordisk Investigational Site | Salisbury | Massachusetts | 01952 | — |
| Novo Nordisk Investigational Site | Waltham | Massachusetts | 02453 | — |
| Novo Nordisk Investigational Site | Detroit | Michigan | 48235 | — |
| Novo Nordisk Investigational Site | Grand Rapids | Michigan | 49506 | — |
| Novo Nordisk Investigational Site | Livonia | Michigan | 48152 | — |
| Novo Nordisk Investigational Site | Saint Cloud | Minnesota | 56303 | — |
| Novo Nordisk Investigational Site | Columbia | Missouri | 65212 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89030 | — |
| Novo Nordisk Investigational Site | Reno | Nevada | 89502-0111 | — |
| Novo Nordisk Investigational Site | Hampton | New Hampshire | 03842 | — |
| Novo Nordisk Investigational Site | Berlin | New Jersey | 08009 | — |
| Novo Nordisk Investigational Site | Turnersville | New Jersey | 08012 | — |
| Novo Nordisk Investigational Site | East Syracuse | New York | 13057 | — |
| Novo Nordisk Investigational Site | New York | New York | 10003 | — |
| Novo Nordisk Investigational Site | New York | New York | 10023 | — |
| Novo Nordisk Investigational Site | Greenville | North Carolina | 27834 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43203 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45406 | — |
| Novo Nordisk Investigational Site | Kettering | Ohio | 45429 | — |
| Novo Nordisk Investigational Site | Medford | Oregon | 97501 | — |
| Novo Nordisk Investigational Site | Melrose Park | Pennsylvania | 19027 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37404 | — |
| Novo Nordisk Investigational Site | Arlington | Texas | 76014 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75235 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-8858 | — |
| Novo Nordisk Investigational Site | Irving | Texas | 75061 | — |
| Novo Nordisk Investigational Site | Midland | Texas | 79707 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Ogden | Utah | 84403 | — |
| Novo Nordisk Investigational Site | Newport News | Virginia | 23606 | — |
| Novo Nordisk Investigational Site | Norfolk | Virginia | 23507 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23249 | — |
| Novo Nordisk Investigational Site | Suffolk | Virginia | 23434 | — |
| Novo Nordisk Investigational Site | Warrenton | Virginia | 20186 | — |
| Novo Nordisk Investigational Site | Kirkland | Washington | 98034 | — |
| Novo Nordisk Investigational Site | Olympia | Washington | 98502 | — |
| Novo Nordisk Investigational Site | Renton | Washington | 98057 | — |
| Novo Nordisk Investigational Site | Tacoma | Washington | 98405 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00097279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2017 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00097279 live on ClinicalTrials.gov.